Xampla announced £2 million in a seed funding round co-led by Amadeus Capital Partners and Cambridge Enterprise
Xampla, a Cambridge, UK-based manufacturer of a plant protein-based material alternative, announced securing funding of £2 million ($2.5M) in seed.
The round was raised from investors co-led by Amadeus Capital Partners and Cambridge Enterprise, with participation from Sky Ocean Ventures and the University of Cambridge Enterprise Fund VI, managed by Parkwalk Advisors. Proceeds will be used for the development of a prototype material into products, such as films, gels and capsules, eventually moving beyond the microcapsule market.
Xampla, founded as a University of Cambridge spin-out by CEO Simon Hombersley, produces next generation material that performs like synthetic polymers, but decomposes naturally and fully, without harming the environment.
The company holds two patents for the new material, with a third in development.